跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-LEFLUNOMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-LEFLUNOMIDE
Authorized
STANDARD
ACCEL-LEFLUNOMIDE
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5e924fc77b31400c
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
5e924fc77b31400c
Drug Approval Canada Name
ACCEL-LEFLUNOMIDE
Product Name
ACCEL-LEFLUNOMIDE
Status
Marketed
Status Date
2019-09-19
Original Market Date
2019-09-19
Din
02478862
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:24.04
Atc Original
L04AK01 LEFLUNOMIDE
Atc Name
l 04 ak 01
Aig Number
0140182001
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
LEFLUNOMIDE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5e924fc77b31400c
Type
Standard
Back to Health Canada Approvals